1. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
    Adrienn Sipos et al, 2021, Molecular Medicine CrossRef
  2. Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer
    Swetlana Gautam et al, 2018, RSC Advances CrossRef
  3. The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor
    Nicolas Creusot et al, 2020, Cells CrossRef
  4. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs
    Magdalena Strachowska et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  5. Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy
    Jianhong Wang et al, 2022, Epilepsy Research CrossRef
  6. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer
    Xiaxia Niu et al, 2022, Cells CrossRef
  7. The Role of CYP3A in Health and Disease
    Lyubov S. Klyushova et al, 2022, Biomedicines CrossRef
  8. Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells
    Tongkuo Yuan et al, 2021, Toxicology CrossRef
  9. Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase
    Peter O. Oladimeji et al, 2017, Scientific Reports CrossRef
  10. The role of bile acids in carcinogenesis
    Tadeja Režen et al, 2022, Cellular and Molecular Life Sciences CrossRef
  11. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules
    Xiang-Qi Zhang et al, 2020, Journal of Ethnopharmacology CrossRef
  12. Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
    Omar Prado-Carrillo et al, 2022, International Journal of Molecular Sciences CrossRef
  13. Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
    Kodye L. Abbott et al, 2022, ACS Omega CrossRef
  14. Herb–Drug Interaction Potential of Licorice Extract and Paclitaxel: A Pharmacokinetic Study in Rats
    Yinuer Ha et al, 2020, European Journal of Drug Metabolism and Pharmacokinetics CrossRef
  15. Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1
    Minqin Xu et al, 2023, The Journal of Biomedical Research CrossRef
  16. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resistance CrossRef
  17. Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library
    Enni-Kaisa Mustonen et al, 2022, Cells CrossRef
  18. The Interface between Cell Signaling Pathways and Pregnane X Receptor
    Robert S. Rogers et al, 2021, Cells CrossRef